Mary E Aronow MD (She/Her)
Retinal Disease, Ocular Oncology
Group Medical Director, Genentech
Join to view full profile
1 DNA WaySouth San Francisco, CA 94080
Phone+1 216-956-6712
Dr. Aronow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mary Beth Aronow is an ophthalmologist with dual fellowship training in ocular oncology and medical retina. She is currently a Group Medical Director in Early Clinical Development at Genentech in San Francisco. Dr. Aronow received her medical degree from Yale University School of Medicine and has been in practice for 13+ years.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Medical Retina, 2013 - 2014
Cleveland Clinic FoundationFellowship, Ocular Oncology/Ophthalmic Pathology, 2010 - 2011- Cleveland Clinic FoundationResidency, Ophthalmology, 2007 - 2010
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
Yale School of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2017 - 2028
MD State Medical License 2013 - 2028
OH State Medical License 2007 - 2013
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2015-2017
Publications & Presentations
PubMed
- 8 citationsClinical histopathology and pathogenesis of macular telangiectasia type 2.Dimitrios P Ntentakis, Anastasia Maria Ntentaki, Eleni Delavogia, Gustavo Sakuno, Victor S M C Corrêa
Progress in Retinal and Eye Research. 2026-01-01 - 2 citationsGrowing choroidal osteoma: Treated by proton beam radiation.Ahad Sedaghat, Mary E Aronow, Arun D Singh
Taiwan Journal of Ophthalmology. 2025-02-17 - Extrascleral Extension of Uveal Melanoma Along Intravitreal Needle Tracts Associated With Periodic Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-...Hursuong Vongsachang, Anna M Stagner, Mary E Aronow, Natalie Wolkow
JAMA Ophthalmology. 2023-08-01
Journal Articles
- Uveal Melanoma: Trends in Incidence, Treatment, and SurvivalArun D Singh, Mary E Turell, Allan K Topham, Ophthalmology
- Quantification of the effect of cross-path motion on the wear rate of ultra-high molecular weight polyethyleneMary Turell, Aiguo Wang, Anuj Bellare, Wear
- A study of the nanostructure and tensile properties of ultra-high molecular weight polyethyleneMB Turell, Anuj Bellare, Biomaterials
Professional Memberships
- Member
- Macula SocietyMember
- International Society of Ocular OncologyMember
- Member
Industry Relationships
- Lead Medical Director, GenentechDisclosure: Salaried employee2022 - Present
External Links
- Google Scholarhttps://scholar.google.com/citations?user=qKXyd1gAAAAJ&hl=en
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: